EDIT:NASDAQ
Editas Medicine Inc
2,17 $
arrow_upward
+1,40%(+0,030) 1D
13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Zacks
·
2 օր առաջ
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc